Last month, the Federal Trade Commission (FTC) filed charges against Breathometer, Inc.–a company that markets two smartphone accessories designed to measure consumers’ BAC–and its CEO in federal court, claiming they lacked scientific evidence to support their claims. The complaint, filed on January 23, 2017 in the U.S. District Court in the Northern District of California, seeks a permanent injunction, rescission of contract, monetary damages, and other equitable relief in connection with the marketing and sale of the applications Breathometer Original ($49) and Breathometer Breeze ($99). The company and its CEO recently settled with the FTC.
Both are devices operated in conjunction with the Breathometer smartphone app. While the Original attaches to a smartphone via the audio jack, the Breeze is operated by Bluetooth. The devices work by blowing into the device. Within seconds, a BAC level is displayed on the phone. The company even had a deal with Uber in which Uber would pick up riders whose BACs were too high to drive.